1149372-04-2

Basic information

• Product Name: ethyl (3S,6bS,8aS,9R,12aS,12bS)-1,3,5,7,8,8a,9,10,11,12,12a,12b-dodecahydro-3,9,12a-trimethyl-5-phenyl-2H-3,6b-methanonaphtho[2',1': 3,4]cyclohepta[1,2-c]pyrazole-9-carboxylate
• Synonyms: ethyl (3S,6bS,8aS,9R,12aS,12bS)-1,3,5,7,8,8a,9,10,11,12,12a,12b-dodecahydro-3,9,12a-trimethyl-5-phenyl-2H-3,6b-methanonaphtho[2',1': 3,4]cyclohepta[1,2-c]pyrazole-9-carboxylate
• CAS NO: 1149372-04-2
• Molecular Weight: 446.633
• Mol File: 1149372-04-2.mol
• Article Data: 2

Chemical Properties

• CAS DataBase Reference: ethyl (3S,6bS,8aS,9R,12aS,12bS)-1,3,5,7,8,8a,9,10,11,12,12a,12b-dodecahydro-3,9,12a-trimethyl-5-phenyl-2H-3,6b-methanonaphtho[2',1': 3,4]cyclohepta[1,2-c]pyrazole-9-carboxylate(CAS DataBase Reference)
• NIST Chemistry Reference: ethyl (3S,6bS,8aS,9R,12aS,12bS)-1,3,5,7,8,8a,9,10,11,12,12a,12b-dodecahydro-3,9,12a-trimethyl-5-phenyl-2H-3,6b-methanonaphtho[2',1': 3,4]cyclohepta[1,2-c]pyrazole-9-carboxylate(1149372-04-2)
• EPA Substance Registry System: ethyl (3S,6bS,8aS,9R,12aS,12bS)-1,3,5,7,8,8a,9,10,11,12,12a,12b-dodecahydro-3,9,12a-trimethyl-5-phenyl-2H-3,6b-methanonaphtho[2',1': 3,4]cyclohepta[1,2-c]pyrazole-9-carboxylate(1149372-04-2)

Safety Data

• Hazardous Substances Data: 1149372-04-2(Hazardous Substances Data)

Upstream product

• 1149372-03-1 C₂₉H₄₂N₂O₂ 
• 27975-19-5 isosteviol 
• 1258238-58-2 ethyl (5β,8α,9β,10α,13α)-8-ethenyl-13-methyl-13-[(E)-(2-phenylhydrazinylidene)methyl]podocarpan-15-oate 
• 1149371-93-6 ethyl (5β,8α,9β,10α,13α)-8-ethenyl-13-formyl-13-methylpodocarpan-15-oate 
• 1149371-92-5 ethyl (15β,16α)-16-hydroxy-15-({[(4-methylphenyl)sulfonyl]oxy}methyl)beyeran-18-oate 
• 160283-49-8 ethyl (4R,4aS,6aR,9S,11aR,11bS)-4,9,11b-trimethyl-8-oxotetradecahydro-6a,9-methanocyclohepta[a]naphthalene-4-carboxylate 
• 882175-41-9 ethyl (15β,16α)-16-hydroxy-15-(hydroxymethyl)beyeran-18-oate 

Relevant articles and documents

Stereoselective synthesis, characterization, and antibacterial activities of novel isosteviol derivatives with D-ring modification

Considerable interests have been attracted by isosteviol and its derivatives because of their large variety of bioactivities. In this project, a series of novel 15- and 16-substituted isosteviol derivatives were stereoselectively prepared by means of func